Ian N Bruce (I N Bruce, Ian Bruce)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 61

Top Topics

Chronic Lymphocytic Leukemia

Systemic Lupus Erythematosus

Disease Activity

Top Venues

Lupus science & medicine

Rheumatology (Oxford, England)

Rheumatology advances in practice

This page only lists publications with an associated author ORCID identifier.

Publications

Marta Mosca, Ian N Bruce, Jeanette Andersen, Manuel F Ugarte-Gil, Laurent Arnaud
Challenges and opportunities in access to care for systemic lupus erythematosus patients across Europe and worldwide. Rheumatology (Oxford, England) 63 (7) (2024)
Anastasia-Vasiliki Madenidou, Hannah Kither, Ian N Bruce
A vasculitis mimic during pregnancy: autoimmune progesterone dermatitis. Rheumatology advances in practice 8 (2) (2024)
Eugene Krustev, John G Hanly, Ricky Chin, Katherine A Buhler, Murray B Urowitz, Caroline Gordon, Sang-Cheol Bae, Juanita Romero-Diaz, Jorge Sánchez-Guerrero, Sasha Bernatsky, Daniel J Wallace, David Isenberg, Anisur Rahman, Joan T Merrill, Paul R Fortin, Dafna D Gladman, Ian N Bruce, Michelle A Petri, Ellen M Ginzler, Mary Anne Dooley, Rosalind Ramsey-Goldman, Susan Manzi, Andreas Jönsen, Graciela S Alarcón, Ronald F Van Vollenhoven, Cynthia Aranow, Meggan Mackay, Guillermo Ruiz-Irastorza, Sung Sam Lim, Murat Inanc, Kenneth C Kalunian, Søren Jacobsen, Christine A Peschken, Diane L Kamen, Anca Askenase, Jill Buyon, Marvin J Fritzler, Ann E Clarke, May Yee Choi
Anti-KIF20B autoantibodies are associated with cranial neuropathy in systemic lupus erythematosus. Lupus science & medicine 11 (1) (2024)
Cynthia Aranow, Cornelia F Allaart, Zahir Amoura, Ian N Bruce, Patricia C Cagnoli, Walter W Chatham, Kenneth L Clark, Richard A Furie, James Groark, Murray B Urowitz, Ronald F Van Vollenhoven, Mark Daniels, Norma Lynn Fox, Yun Irene Gregan, Robert B Henderson, André van Maurik, Josephine C Ocran-Appiah, Mary Oldham, David A Roth, Don Shanahan, Paul P Tak, Y K Onno Teng
Efficacy and safety of sequential therapy with subcutaneous belimumab and one cycle of rituximab in patients with systemic lupus erythematosus: the phase 3, randomised, placebo-controlled BLISS-BELIEVE study. Annals of the rheumatic diseases (2024)
Jessica C Ellis, Neil McHugh, John D Pauling, Ian N Bruce, Rachel Charlton, Anita McGrogan, Sarah Skeoch
Changes in the incidence and prevalence of systemic lupus erythematosus between 1990 and 2020: an observational study using the Clinical Practice Research Datalink (CPRD). Lupus science & medicine 11 (2) (2024)
Anca D Askanase, Richard A Furie, Maria Dall'Era, Andrew S Bomback, Andreas Schwarting, Ming-Hui Zhao, Ian N Bruce, Munther Khamashta, Bernie Rubin, Angela Carroll, Mark Daniels, Roger Abramino Levy, Ronald F Van Vollenhoven, Murray B Urowitz
Disease-modifying therapies in systemic lupus erythematosus for extrarenal manifestations. Lupus science & medicine 11 (1) (2024)
Anca D Askanase, Richard A Furie, Maria Dall'Era, Andrew S Bomback, Andreas Schwarting, Ming-Hui Zhao, Ian N Bruce, Munther Khamashta, Bernie Rubin, Angela Carroll, Mark Daniels, Roger Abramino Levy, Ronald F Van Vollenhoven, Murray B Urowitz
Disease-modifying therapies in systemic lupus erythematosus for extrarenal manifestations. Lupus science & medicine 11 (1) (2024)
Eugene Krustev, John G Hanly, Ricky Chin, Katherine A Buhler, Murray B Urowitz, Caroline Gordon, Sang-Cheol Bae, Juanita Romero-Diaz, Jorge Sánchez-Guerrero, Sasha Bernatsky, Daniel J Wallace, David Isenberg, Anisur Rahman, Joan T Merrill, Paul R Fortin, Dafna D Gladman, Ian N Bruce, Michelle A Petri, Ellen M Ginzler, Mary Anne Dooley, Rosalind Ramsey-Goldman, Susan Manzi, Andreas Jönsen, Graciela S Alarcón, Ronald F Van Vollenhoven, Cynthia Aranow, Meggan Mackay, Guillermo Ruiz-Irastorza, Sung Sam Lim, Murat Inanc, Kenneth C Kalunian, Søren Jacobsen, Christine A Peschken, Diane L Kamen, Anca Askenase, Jill Buyon, Marvin J Fritzler, Ann E Clarke, May Yee Choi
Anti-KIF20B autoantibodies are associated with cranial neuropathy in systemic lupus erythematosus. Lupus science & medicine 11 (1) (2024)
Marta Mosca, Ian N Bruce, Jeanette Andersen, Manuel F Ugarte-Gil, Laurent Arnaud
Challenges and opportunities in access to care for systemic lupus erythematosus patients across Europe and worldwide. Rheumatology (Oxford, England) 63 (7) (2024)
Eugene Krustev, John G Hanly, Ricky Chin, Katherine A Buhler, Murray B Urowitz, Caroline Gordon, Sang-Cheol Bae, Juanita Romero-Diaz, Jorge Sánchez-Guerrero, Sasha Bernatsky, Daniel J Wallace, David Isenberg, Anisur Rahman, Joan T Merrill, Paul R Fortin, Dafna D Gladman, Ian N Bruce, Michelle A Petri, Ellen M Ginzler, Mary Anne Dooley, Rosalind Ramsey-Goldman, Susan Manzi, Andreas Jönsen, Graciela S Alarcón, Ronald F Van Vollenhoven, Cynthia Aranow, Meggan Mackay, Guillermo Ruiz-Irastorza, Sung Sam Lim, Murat Inanc, Kenneth C Kalunian, Søren Jacobsen, Christine A Peschken, Diane L Kamen, Anca Askenase, Jill Buyon, Marvin J Fritzler, Ann E Clarke, May Yee Choi
Anti-KIF20B autoantibodies are associated with cranial neuropathy in systemic lupus erythematosus. Lupus science & medicine 11 (1) (2024)
Eugene Krustev, John G Hanly, Ricky Chin, Katherine A Buhler, Murray B Urowitz, Caroline Gordon, Sang-Cheol Bae, Juanita Romero-Diaz, Jorge Sánchez-Guerrero, Sasha Bernatsky, Daniel J Wallace, David Isenberg, Anisur Rahman, Joan T Merrill, Paul R Fortin, Dafna D Gladman, Ian N Bruce, Michelle A Petri, Ellen M Ginzler, Mary Anne Dooley, Rosalind Ramsey-Goldman, Susan Manzi, Andreas Jönsen, Graciela S Alarcón, Ronald F Van Vollenhoven, Cynthia Aranow, Meggan Mackay, Guillermo Ruiz-Irastorza, Sung Sam Lim, Murat Inanc, Kenneth C Kalunian, Søren Jacobsen, Christine A Peschken, Diane L Kamen, Anca Askenase, Jill Buyon, Marvin J Fritzler, Ann E Clarke, May Yee Choi
Anti-KIF20B autoantibodies are associated with cranial neuropathy in systemic lupus erythematosus. Lupus science & medicine 11 (1) (2024)
Eugene Krustev, John G Hanly, Ricky Chin, Katherine A Buhler, Murray B Urowitz, Caroline Gordon, Sang-Cheol Bae, Juanita Romero-Diaz, Jorge Sánchez-Guerrero, Sasha Bernatsky, Daniel J Wallace, David Isenberg, Anisur Rahman, Joan T Merrill, Paul R Fortin, Dafna D Gladman, Ian N Bruce, Michelle A Petri, Ellen M Ginzler, Mary Anne Dooley, Rosalind Ramsey-Goldman, Susan Manzi, Andreas Jönsen, Graciela S Alarcón, Ronald F Van Vollenhoven, Cynthia Aranow, Meggan Mackay, Guillermo Ruiz-Irastorza, Sung Sam Lim, Murat Inanc, Kenneth C Kalunian, Søren Jacobsen, Christine A Peschken, Diane L Kamen, Anca Askenase, Jill Buyon, Marvin J Fritzler, Ann E Clarke, May Yee Choi
Anti-KIF20B autoantibodies are associated with cranial neuropathy in systemic lupus erythematosus. Lupus science & medicine 11 (1) (2024)
Eugene Krustev, John G Hanly, Ricky Chin, Katherine A Buhler, Murray B Urowitz, Caroline Gordon, Sang-Cheol Bae, Juanita Romero-Diaz, Jorge Sánchez-Guerrero, Sasha Bernatsky, Daniel J Wallace, David Isenberg, Anisur Rahman, Joan T Merrill, Paul R Fortin, Dafna D Gladman, Ian N Bruce, Michelle A Petri, Ellen M Ginzler, Mary Anne Dooley, Rosalind Ramsey-Goldman, Susan Manzi, Andreas Jönsen, Graciela S Alarcón, Ronald F Van Vollenhoven, Cynthia Aranow, Meggan Mackay, Guillermo Ruiz-Irastorza, Sung Sam Lim, Murat Inanc, Kenneth C Kalunian, Søren Jacobsen, Christine A Peschken, Diane L Kamen, Anca Askenase, Jill Buyon, Marvin J Fritzler, Ann E Clarke, May Yee Choi
Anti-KIF20B autoantibodies are associated with cranial neuropathy in systemic lupus erythematosus. Lupus science & medicine 11 (1) (2024)
Eugene Krustev, John G Hanly, Ricky Chin, Katherine A Buhler, Murray B Urowitz, Caroline Gordon, Sang-Cheol Bae, Juanita Romero-Diaz, Jorge Sánchez-Guerrero, Sasha Bernatsky, Daniel J Wallace, David Isenberg, Anisur Rahman, Joan T Merrill, Paul R Fortin, Dafna D Gladman, Ian N Bruce, Michelle A Petri, Ellen M Ginzler, Mary Anne Dooley, Rosalind Ramsey-Goldman, Susan Manzi, Andreas Jönsen, Graciela S Alarcón, Ronald F Van Vollenhoven, Cynthia Aranow, Meggan Mackay, Guillermo Ruiz-Irastorza, Sung Sam Lim, Murat Inanc, Kenneth C Kalunian, Søren Jacobsen, Christine A Peschken, Diane L Kamen, Anca Askenase, Jill Buyon, Marvin J Fritzler, Ann E Clarke, May Yee Choi
Anti-KIF20B autoantibodies are associated with cranial neuropathy in systemic lupus erythematosus. Lupus science & medicine 11 (1) (2024)
Jessica C Ellis, Neil McHugh, John D Pauling, Ian N Bruce, Rachel Charlton, Anita McGrogan, Sarah Skeoch
Changes in the incidence and prevalence of systemic lupus erythematosus between 1990 and 2020: an observational study using the Clinical Practice Research Datalink (CPRD). Lupus science & medicine 11 (2) (2024)
Marta Mosca, Ian N Bruce, Jeanette Andersen, Manuel F Ugarte-Gil, Laurent Arnaud
Challenges and opportunities in access to care for systemic lupus erythematosus patients across Europe and worldwide. Rheumatology (Oxford, England) 63 (7) (2024)
Anca D Askanase, Richard A Furie, Maria Dall'Era, Andrew S Bomback, Andreas Schwarting, Ming-Hui Zhao, Ian N Bruce, Munther Khamashta, Bernie Rubin, Angela Carroll, Mark Daniels, Roger Abramino Levy, Ronald F Van Vollenhoven, Murray B Urowitz
Disease-modifying therapies in systemic lupus erythematosus for extrarenal manifestations. Lupus science & medicine 11 (1) (2024)
Anca D Askanase, Richard A Furie, Maria Dall'Era, Andrew S Bomback, Andreas Schwarting, Ming-Hui Zhao, Ian N Bruce, Munther Khamashta, Bernie Rubin, Angela Carroll, Mark Daniels, Roger Abramino Levy, Ronald F Van Vollenhoven, Murray B Urowitz
Disease-modifying therapies in systemic lupus erythematosus for extrarenal manifestations. Lupus science & medicine 11 (1) (2024)
Anastasia-Vasiliki Madenidou, Hannah Kither, Ian N Bruce
A vasculitis mimic during pregnancy: autoimmune progesterone dermatitis. Rheumatology advances in practice 8 (2) (2024)
Jessica C Ellis, Neil McHugh, John D Pauling, Ian N Bruce, Rachel Charlton, Anita McGrogan, Sarah Skeoch
Changes in the incidence and prevalence of systemic lupus erythematosus between 1990 and 2020: an observational study using the Clinical Practice Research Datalink (CPRD). Lupus science & medicine 11 (2) (2024)
Ian N Bruce, Ronald F Van Vollenhoven, Konstantina Psachoulia, Catharina Lindholm, Emmanuelle Maho, Raj Tummala
Time to onset of clinical response to anifrolumab in patients with SLE: pooled data from the phase III TULIP-1 and TULIP-2 trials. Lupus science & medicine 10 (1) (2023)
Gwenda Simons, Ellen M Janssen, Jorien Veldwijk, Rachael L DiSantostefano, Matthias Englbrecht, Christine A Radawski, Larissa Valor-Méndez, Jennifer H Humphreys, Ian N Bruce, A Brett Hauber, Karim Raza, Marie Falahee
Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance. RMD open 8 (2) (2023)
Ian N Bruce
Health inequalities and systemic lupus erythematosus: a global challenge. Rheumatology (Oxford, England) 62 (Supplement_1) (2023)
Ian N Bruce
Health inequalities and systemic lupus erythematosus: a global challenge. Rheumatology (Oxford, England) 62 (Supplement_1) (2023)
M L Barraclough, J P Diaz-Martinez, A Knight, K Bingham, J Su, M Kakvan, C Muñoz Grajales, M C Tartaglia, L Ruttan, J Wither, M Y Choi, D Bonilla, N Anderson, S Appenzeller, B Parker, Patricia P Katz, D Beaton, R Green, Ian N Bruce, Zahi Touma
In-person versus virtual administration of the American College of Radiology gold standard cognitive battery in systemic lupus erythematosus: Are they interchangeable? Lupus (2023)
Ian N Bruce, Joy Jones Buie, Lauren Bloch, Sang-Cheol Bae, Karen Costenbader, Roger Abramino Levy, Victoria P Werth, Ashley Marion, Sanjyot Sangodkar, Susan Manzi
Lupus spectrum ambiguity has long-term negative implications for patients. Lupus science & medicine 10 (1) (2023)
Ian N Bruce, Ronald F Van Vollenhoven, Konstantina Psachoulia, Catharina Lindholm, Emmanuelle Maho, Raj Tummala
Time to onset of clinical response to anifrolumab in patients with SLE: pooled data from the phase III TULIP-1 and TULIP-2 trials. Lupus science & medicine 10 (1) (2023)
Ian N Bruce
Health inequalities and systemic lupus erythematosus: a global challenge. Rheumatology (Oxford, England) 62 (Supplement_1) (2023)
Gwenda Simons, Ellen M Janssen, Jorien Veldwijk, Rachael L DiSantostefano, Matthias Englbrecht, Christine A Radawski, Larissa Valor-Méndez, Jennifer H Humphreys, Ian N Bruce, A Brett Hauber, Karim Raza, Marie Falahee
Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance. RMD open 8 (2) (2023)
Gwenda Simons, Ellen M Janssen, Jorien Veldwijk, Rachael L DiSantostefano, Matthias Englbrecht, Christine A Radawski, Larissa Valor-Méndez, Jennifer H Humphreys, Ian N Bruce, A Brett Hauber, Karim Raza, Marie Falahee
Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance. RMD open 8 (2) (2023)
Gwenda Simons, Ellen M Janssen, Jorien Veldwijk, Rachael L DiSantostefano, Matthias Englbrecht, Christine A Radawski, Larissa Valor-Méndez, Jennifer H Humphreys, Ian N Bruce, A Brett Hauber, Karim Raza, Marie Falahee
Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance. RMD open 8 (2) (2023)
Ian N Bruce, Ronald F Van Vollenhoven, Konstantina Psachoulia, Catharina Lindholm, Emmanuelle Maho, Raj Tummala
Time to onset of clinical response to anifrolumab in patients with SLE: pooled data from the phase III TULIP-1 and TULIP-2 trials. Lupus science & medicine 10 (1) (2023)
Gwenda Simons, Ellen M Janssen, Jorien Veldwijk, Rachael L DiSantostefano, Matthias Englbrecht, Christine A Radawski, Larissa Valor-Méndez, Jennifer H Humphreys, Ian N Bruce, A Brett Hauber, Karim Raza, Marie Falahee
Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance. RMD open 8 (2) (2023)
Gwenda Simons, Ellen M Janssen, Jorien Veldwijk, Rachael L DiSantostefano, Matthias Englbrecht, Christine A Radawski, Larissa Valor-Méndez, Jennifer H Humphreys, Ian N Bruce, A Brett Hauber, Karim Raza, Marie Falahee
Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance. RMD open 8 (2) (2023)
Gwenda Simons, Ellen M Janssen, Jorien Veldwijk, Rachael L DiSantostefano, Matthias Englbrecht, Christine A Radawski, Larissa Valor-Méndez, Jennifer H Humphreys, Ian N Bruce, A Brett Hauber, Karim Raza, Marie Falahee
Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance. RMD open 8 (2) (2023)
Ian N Bruce
Health inequalities and systemic lupus erythematosus: a global challenge. Rheumatology (Oxford, England) 62 (Supplement_1) (2023)
Trixy David, Li Su, Yafeng Cheng, Caroline Gordon, Benjamin Parker, David Alan Isenberg, John A Reynolds, Ian N Bruce, null null, null null
Predictors of British Isles Lupus Assessment Group-based outcomes in patients with systemic lupus erythematosus: Analysis from the Systemic Lupus International Collaborating Clinics Inception Cohort. Lupus (2023)
Ian N Bruce, Ronald F Van Vollenhoven, Konstantina Psachoulia, Catharina Lindholm, Emmanuelle Maho, Raj Tummala
Time to onset of clinical response to anifrolumab in patients with SLE: pooled data from the phase III TULIP-1 and TULIP-2 trials. Lupus science & medicine 10 (1) (2023)
Gwenda Simons, Ellen M Janssen, Jorien Veldwijk, Rachael L DiSantostefano, Matthias Englbrecht, Christine A Radawski, Larissa Valor-Méndez, Jennifer H Humphreys, Ian N Bruce, A Brett Hauber, Karim Raza, Marie Falahee
Acceptable risks of treatments to prevent rheumatoid arthritis among first-degree relatives: demographic and psychological predictors of risk tolerance. RMD open 8 (2) (2023)
Ian N Bruce, Sarowar Golam, Jason Steenkamp, Pearl Wang, Evelyn Worthington, Barnabas Desta, Konstantina Psachoulia, Wilma Erhardt, Raj Tummala
Letter in reply: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus. Journal of comparative effectiveness research 12 (1) (2022)
Chee-Seng Yee, Munther Khamashta, Mohammed Akil, Rachael Kilding, Ian Giles, David Williams, Ian N Bruce, Caroline Gordon
The BILAG2004-Pregnancy Index is a valid disease activity outcome measure for pregnant SLE patients. Rheumatology advances in practice 6 (3) (2022)
Alyssa C Gilmore, Hannah R Wilson, Thomas D Cairns, Marina Botto, Liz Lightstone, Ian N Bruce, Herbert Terence Cook, Matthew Caleb Pickering, null null
Immune gene expression and functional networks in distinct lupus nephritis classes. Lupus science & medicine 9 (1) (2022)
Ian N Bruce, Sarowar Golam, Jason Steenkamp, Pearl Wang, Evelyn Worthington, Barnabas Desta, Konstantina Psachoulia, Wilma Erhardt, Raj Tummala
Indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus. Journal of comparative effectiveness research 11 (10) (2022)
Lucy Marie Carter, Caroline Gordon, Chee-Seng Yee, Ian N Bruce, David Alan Isenberg, Sarah Skeoch, Edward M Vital
Easy-BILAG: a new tool for simplified recording of SLE disease activity using BILAG-2004 index. Rheumatology (Oxford, England) 61 (10) (2022)
Ian N Bruce, Richard A Furie, Eric F Morand, Susan Manzi, Yoshiya Tanaka, Kenneth C Kalunian, Joan T Merrill, Patricia Puzio, Emmanuelle Maho, Christi Kleoudis, Marius Albulescu, Micki Hultquist, Raj Tummala
Concordance and discordance in SLE clinical trial outcome measures: analysis of three anifrolumab phase 2/3 trials. Annals of the rheumatic diseases 81 (7) (2022)
Ryan Malcolm Hum, Trixy David, Yen June Lau, Hajira Iftikhar, Sue Thornber, Louise Simcox, Ian N Bruce, Clare Tower, Pauline Ho
Pregnancy outcomes of a joint obstetric and rheumatology clinic in a tertiary centre: a 2-year retrospective study of 98 pregnancies. Rheumatology advances in practice 6 (1) (2022)
Celline C Almeida-Brasil, John G Hanly, Murray B Urowitz, Ann Elaine Clarke, Guillermo Ruiz-Irastorza, Caroline Gordon, Rosalind Ramsey-Goldman, Michelle A Petri, Ellen M Ginzler, Daniel J Wallace, Sang-Cheol Bae, Juanita Romero-Diaz, Mary-Anne Dooley, Christine Peschken, David Isenberg, Anisur Rahman, Susan Manzi, Søren Jacobsen, Sung Sam Lim, Ronald van Vollenhoven, Ola Nived, Andreas Jönsen, Diane L Kamen, Cynthia Aranow, Jorge Sánchez-Guerrero, Dafna D Gladman, Paul R Fortin, Graciela S Alarcon, Joan T Merrill, Kenneth Kalunian, Manuel Ramos-Casals, Kristjan Steinsson, A Zoma, Anca D Askanase, Munther Khamashta, Ian N Bruce, Murat Inanc, Luck Lukusa, Sasha Bernatsky
Retinal toxicity in a multinational inception cohort of patients with systemic lupus on hydroxychloroquine. Lupus science & medicine 9 (1) (2022)
Ian N Bruce, Sarowar Golam, Jason Steenkamp, Pearl Wang, Evelyn Worthington, Barnabas Desta, Konstantina Psachoulia, Wilma Erhardt, Raj Tummala
Letter in reply: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus. Journal of comparative effectiveness research (2022)
Manuel Francisco Ugarte-Gil, Anselm Mak, Joanna Leong, Bhushan Dharmadhikari, Nien Yee Kow, Cristina Reatégui-Sokolova, Claudia Elera-Fitzcarrald, Cinthia Aranow, Laurent Arnaud, Anca D Askanase, Sang-Cheol Bae, Sasha Bernatsky, Ian N Bruce, Jill Buyon, Nathalie Costedoat-Chalumeau, Mary Ann Dooley, Paul R Fortin, Ellen M Ginzler, Dafna D Gladman, John Hanly, Murat Inanc, David Isenberg, Soren Jacobsen, Judith A James, Andreas Jönsen, Kenneth Kalunian, Diane L Kamen, Sung Sam Lim, Eric F Morand, Marta Mosca, Christine Peschken, Bernardo A Pons-Estel, Anisur Rahman, Rosalind Ramsey-Goldman, John Reynolds, Juanita Romero-Diaz, Guillermo Ruiz-Irastorza, Jorge Sánchez-Guerrero, Elisabet Svenungsson, Murray B Urowitz, Evelyne Vinet, Ronald F Van Vollenhoven, Alexandre Voskuyl, Daniel J Wallace, Michelle A Petri, Susan Manzi, Ann Elaine Clarke, Mike Cheung, Vernon Farewell, Graciela S Alarcon
Impact of glucocorticoids on the incidence of lupus-related major organ damage: a systematic literature review and meta-regression analysis of longitudinal observational studies. Lupus science & medicine 8 (1) (2022)
Francesca S Cardwell, Susan J Elliott, Ricky Chin, Yvan St Pierre, May Yee Choi, Murray B Urowitz, Guillermo Ruiz-Irastorza, Sasha Bernatsky, Daniel J Wallace, Michelle A Petri, Susan Manzi, Sang-Cheol Bae, Jung-Min Shin, Anselm Mak, Jiacai Cho, Christine A Peschken, Rosalind Ramsey-Goldman, Paul R Fortin, John G Hanly, Bernardo A Pons-Estel, Romina Nieto, Anca D Askanase, Juanita Romero-Diaz, Marta Mosca, Ian N Bruce, Leigha Rowbottom, Leanne Mielczarek, Karin Tse, Ashley Marion, Juan Carlos Cáhiz-González, Teresa G Cattoni, Alain Cornet, Ann Elaine Clarke
Health information use by patients with systemic lupus erythematosus (SLE) pre and during the COVID-19 pandemic. Lupus science & medicine 9 (1) (2022)
Ronald F Van Vollenhoven, Anca D Askanase, Andrew S Bomback, Ian N Bruce, Angela Carroll, Maria Dall'Era, Mark Daniels, Roger Abramino Levy, Andreas Schwarting, Holly A Quasny, Murray B Urowitz, Ming-Hui Zhao, Richard A Furie
Conceptual framework for defining disease modification in systemic lupus erythematosus: a call for formal criteria. Lupus science & medicine 9 (1) (2022)
Stephen McDonald, Sean Yiu, Li Su, Caroline Gordon, Matt Truman, Laura Lisk, Neil Solomons, Ian N Bruce, null null
Predictors of treatment response in a lupus nephritis population: lessons from the Aspreva Lupus Management Study (ALMS) trial. Lupus science & medicine 9 (1) (2022)
Ronald F Van Vollenhoven, George Bertsias, Andrea Doria, David Isenberg, Eric F Morand, Michelle A Petri, Bernardo A Pons-Estel, Anisur Rahman, Manuel Francisco Ugarte-Gil, Alexandre Voskuyl, Laurent Arnaud, Ian N Bruce, Ricard Cervera, Nathalie Costedoat-Chalumeau, Caroline Gordon, Frederic A Houssiau, Marta Mosca, Matthias Schneider, Michael M Ward, Graciela Alarcon, Martin Aringer, Anka Askenase, Sang-Cheol Bae, Hendrika Bootsma, Dimitrios T Boumpas, Hermine I Brunner, Ann Elaine Clarke, Cindy Coney, László Czirják, Thomas Dörner, Raquel Faria, Rebecca Fischer, Ruth Fritsch-Stork, Murat Inanc, Søren Jacobsen, David Jayne, Annegret Kuhn, Bernadette van Leeuw, Maarten Limper, Xavier Mariette, Sandra Navarra, Mandana Nikpour, Marzena Helena Olesinska, Guillermo Pons-Estel, Juanita Romero-Diaz, Blanca Rubio, Yehuda Schoenfeld, Eloisa Bonfá, Josef Smolen, Y K Onno Teng, Angela Tincani, Michel W P Tsang-A-Sjoe, Carlos Vasconcelos, Anne Voss, Victoria P Werth, Elena Zakharhova, Cynthia Aranow
2021 DORIS definition of remission in SLE: final recommendations from an international task force. Lupus science & medicine 8 (1) (2022)
Ian N Bruce, Sarowar Golam, Jason Steenkamp, Pearl Wang, Evelyn Worthington, Barnabas Desta, Konstantina Psachoulia, Wilma Erhardt, Raj Tummala
Letter in reply: indirect treatment comparison of anifrolumab efficacy versus belimumab in adults with systemic lupus erythematosus. Journal of comparative effectiveness research 12 (1) (2022)
John A Reynolds, Jennifer Prattley, Nophar Geifman, Mark Lunt, Caroline Gordon, Ian N Bruce, null null
Distinct patterns of disease activity over time in patients with active SLE revealed using latent class trajectory models. Arthritis research & therapy 23 (1) (2021)
Michelle Barraclough, Shane McKie, Ben Parker, Rebecca Elliott, Ian N Bruce
The effects of disease activity, inflammation, depression and cognitive fatigue on resting state fMRI in systemic lupus erythematosus. Rheumatology (Oxford, England) (2021)
Sarah Dyball, Sophie Collinson, Emily Sutton, Eoghan M McCarthy, Ian N Bruce, Ben Parker
Lupus clinical trial eligibility in a real-world setting: results from the British Isles Lupus Assessment Group-Biologics Register (BILAG-BR). Lupus science & medicine 8 (1) (2021)
R E Costello, J H Humphreys, J C Sergeant, M Haris, F Stirling, K Raza, D van Schaardenburg, Ian N Bruce
Symptoms in first-degree relatives of patients with rheumatoid arthritis: evaluation of cross-sectional data from the symptoms in persons at risk of rheumatoid arthritis (SPARRA) questionnaire in the PRe-clinical EValuation of Novel Targets in RA (PREVeNT-RA) Cohort. Arthritis research & therapy 23 (1) (2021)
Megan R W Barber, Sindhu R Johnson, Dafna D Gladman, Ann Elaine Clarke, Ian N Bruce
Evolving concepts in systemic lupus erythematosus damage assessment. Nature reviews. Rheumatology 17 (6) (2021)
Richard A Furie, Ian N Bruce, Thomas Dörner, Manuel Gustavo Leon, Piotr Leszczyński, Murray Urowitz, Birgit Haier, Teri Jimenez, Claire Brittain, Jiajun Liu, Catherine Barbey, Christian Stach
Phase 2, randomized, placebo-controlled trial of dapirolizumab pegol in patients with moderate-to-severe active systemic lupus erythematosus. Rheumatology (Oxford, England) 60 (11) (2021)
John A Reynolds, Tracy A Briggs, Gillian I Rice, Sathya Darmalinggam, Vincent Bondet, Ellen Bruce, Mumtaz Khan, Sahena Haque, Hector Chinoy, Ariane L Herrick, Eoghan M McCarthy, Leo Zeef, Andrew Hayes, Darragh Duffy, Ben Parker, Ian N Bruce
Type I interferon in patients with systemic autoimmune rheumatic disease is associated with haematological abnormalities and specific autoantibody profiles. Arthritis research & therapy 21 (1) (2019)